GFAP and Alzheimer disease: In a research combining neurofilament light and other biomarkers for diagnosis of AD, the risk of dementia-specific death was significantly elevated in individuals with high serum concentrations of both neurofilament light and glial fibrillary acidic protein, compared to those with low levels of both biomarkers29.